The stent delivery systems market is anticipated to register a CAGR of 7% during the forecast period, up from US$ 11.03 Bn in 2022 to reach a valuation of US$ 21.7 Bn by 2032.
The stent delivery systems market is anticipated to show promising growth prospects during the forecast period.
| Attributes | Details |
|---|---|
| Stent Delivery Systems Market Value (2022) | US$ 11.03 Billion |
| Stent Delivery Systems Market Projected Value (2032) | US$ 21.7 Billion |
| Stent Delivery Systems Market CAGR (2022 to 2032) | 7% |
One of the primary factors driving the growth of the stent delivery systems market share is the increasing number of patients with coronary artery disease. Furthermore, the sales of stent delivery systems is rising due to the healthcare industry's massive transformation over the last decade. This has resulted in several advances and various minimally invasive surgeries, which are likely to positively fuel the demand for stent delivery systems and the expansion of the global stent delivery systems market in the approaching years.
The sales of stent delivery systems is rising rapidly owing to continuous research and development operations which results in effective stent delivery methods that minimise friction during stent installation. Thus, the demand for stent delivery systems is rising as it reduces the danger of medical errors and increasing patient conformance during the medical treatment.
As a result, the global stent delivery systems market is predicted to expand substantially during the forecast period. In addition, breakthrough technologies like self-expanding stents that have recently been developed are likely to increase market demand for stent delivery systems. As a result of this, the sales of stent delivery systems is likely to rise during the forecast period.
Furthermore, the global stent delivery systems market's leading manufacturers have released a multi stent delivery system that is preloaded with six tiny stents and has the ability to reduce the risk of thrombosis and restenosis by naturally managing artery motion. As a result of these reasons, the demand for stent delivery systems is expected to grow in the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for stent delivery systems is increasing as it aids in the placement of stents into arteries and narrow blood channels in order to open them and guarantee appropriate blood flow. The stents are made of nickel and titanium and have a self-expanding nitinol construction, which is a primary factor responsible for growing sales of stent delivery systems.
On the stent delivery systems, the stents are preloaded. The stent delivery system is also simple to use, with a modular design and a single operator. Due to these factors the demand for stent delivery systems is anticipated to rise. The sales of stent delivery systems is growing as it reduces friction during deployment, allowing for precise stent insertion. High operation costs and the scarcity of surgeons are two problems that may stimulate stent delivery systems market expansion.
The emergence of new technologies and advancements in stent delivery systems have resulted in a reduction in technical faults and assistance in releasing the stents at the required targets, increasing the sales of stent delivery systems and expanding the global stent delivery systems market share.
The demand for stent delivery systems is being driven by a rise in minimally invasive surgeries. One of the primary factors driving the stent delivery systems market share is the increasing prevalence of atherosclerosis and arterial diseases. The development of self-expanding stents and innovative technologies is augmenting the sales of stent delivery systems.
Rising research activity, as well as increased regulatory approvals, are some of the drivers driving the expansion of stent delivery systems market share. Some of the reasons driving the sales of stent delivery systems include an increase in the number of research activities focusing on stent delivery systems and an increase in regulatory approvals. As healthcare improves, healthcare facilities and hospitals are shifting their attention to a more value-based system.
These stent delivery systems are also utilized on patients who are undergoing percutaneous coronary intervention procedures. These reasons encourage R&D and medical departments to overcome limitations in order to develop better alternative stent delivery systems.
Geographically, the market for stent delivery systems is divided into North America, Europe, Latin America, Asia-Pacific, Japan, and the Middle East and Africa. Due to the increasing number of patients suffering from cardiac ailments and blockages, the North American region is predicted to lead the global stent delivery systems market share, followed by Europe.
Furthermore, the availability of modern goods that replace traditional systems is increasing in the United States, which is likely to enhance the demand for Stent delivery systems in the region. The patient is made more comfortable by the new modern systems.
The Asia Pacific stent delivery systems market is predicted to grow at a faster rate due to an increasing geriatric population, which is expected to enhance the sales of stent delivery systems. Furthermore, countries in the Asia Pacific and Latin America, such as India and China, are predicted to see faster revenue growth in stent delivery systems market during the forecast period.
Principal Consultant
Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc., Stryker Corporation, ELLA - CS, s.r.o., Becton, Dickinson and Company, Svelte Medical, Abbott, Terumo Europe NV, and others are among the key players in the stent delivery systems market. Furthermore, stent delivery system market manufacturers are primarily focused on enhancing and expanding the key competencies of their product range.
Recent Developments
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 7% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors and trends, Pricing Analysis |
| Segments covered | Product type, Indications, End user, region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Boston Scientific Corporation; B. Braun Melsungen AG; Medtronic Plc.; Stryker Corporation; ELLA - CS; s.r.o.; Becton; Dickinson and Company; Svelte Medical; Abbott; Terumo Europe NV |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The stent delivery systems market is forecasted to register a CAGR of 7% during the forecast period.
Key players holding substantial Stent Delivery Systems Market share include Boston Scientific Corporation, B. Braun Melsungen AG, Medtronic Plc., Stryker Corporation, ELLA - CS, s.r.o., Becton, Dickinson and Company, Svelte Medical, Abbott, Terumo Europe NV.
As per the analysis, the stent delivery systems market share is likely to be US$ 21.7 Bn by 2032.
Demand for stent delivery systems is likely to rise due to the increasing number of patients with coronary artery disease.
Explore Healthcare Insights
View Reports
Stent Delivery Systems Market
